For research use only. Not for therapeutic Use.
5-R-Rivaroxaban is an active enantiomer of rivaroxaban, a potent oral anticoagulant used primarily for the prevention and treatment of thromboembolic disorders. This compound works by selectively inhibiting factor Xa, a key enzyme in the coagulation cascade, thereby reducing the risk of blood clots. Research on 5-R-rivaroxaban focuses on its pharmacokinetics and pharmacodynamics, aiming to optimize dosing regimens and enhance therapeutic efficacy. Its safety profile and effectiveness make it a crucial component in modern anticoagulant therapy.
| Catalog Number | I005204 |
| CAS Number | 865479-71-6 |
| Synonyms | 5-chloro-N-[[(5R)-2-oxo-3-[4-(3-oxomorpholin-4-yl)phenyl]-1,3-oxazolidin-5-yl]methyl]thiophene-2-carboxamide |
| Molecular Formula | C19H18ClN3O5S |
| Purity | ≥95% |
| Target | Factor Xa |
| Solubility | 10 mM in DMSO |
| Storage | Store at -20°C |
| InChI | 1S/C19H18ClN3O5S/c20-16-6-5-15(29-16)18(25)21-9-14-10-23(19(26)28-14)13-3-1-12(2-4-13)22-7-8-27-11-17(22)24/h1-6,14H,7-11H2,(H,21,25)/t14-/m1/s1 |
| InChIKey | KGFYHTZWPPHNLQ-CQSZACIVSA-N |
| SMILES | C1COCC(=O)N1C2=CC=C(C=C2)N3C[C@H](OC3=O)CNC(=O)C4=CC=C(S4)Cl |
